Tata Nifty MidSmall Healthcare Index Fund
(An open-ended scheme replicating/tracking Nifty MidSmall Healthcare Index (TRI)) |
![]() |
As on 28th February 2025
![]() ![]() |
An open-ended scheme replicating/tracking Nifty Assets MidSmall Healthcare Index (TRI)
INVESTMENT OBJECTIVE:The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns.
DATE OF ALLOTMENT:April 26, 2024
FUND MANAGER(S)Kapil Menon (Managing Since 26-Apr-24 and overall experience of 21 years)
ASSISTANT FUND MANAGER:Rakesh Indrajeet Prajapati (Managing Since 20-Dec-24 and overall experience of 19 years)
BENCHMARK:Nifty MidSmall Healthcare TRI
NAV (in Rs.)Direct - Growth | : 10.9300 |
Direct - IDCW | : 10.9300 |
Reg - Growth | : 10.8631 |
Reg - IDCW | : 10.8631 |
FUND SIZE | |
Rs. 118.94 (Rs. in Cr.) | |
MONTHLY AVERAGE AUM | |
Rs. 125.37 (Rs. in Cr.) | |
TURN OVER | |
Portfolio Turnover (Equity component only) | 11.90% |
EXPENSE RATIO** | |
Direct | 0.47 |
Regular | 1.10 |
**Note: The rates specified are actual month end expenses charged as on Feb 28, 2025. The above ratio includes the GST on Investment Management Fees. The above ratio excludes, borrowing cost, wherever applicable. |
^Risk-free rate based on the FBIL Overnight MIBOR rate of 6.4% as
on Feb 28, 2025 For calculation methodology |
Rs. 5,000/- and in multiples of Re. 1/- thereafter.
ADDITIONAL INVESTMENT/Rs. 1,000/- and multiples of Re. 1/- thereafter.
LOAD STRUCTURE:ENTRY LOAD | Not Applicable |
EXIT LOAD |
0.25 % of the applicable NAV, if
redeemed on or before 15 days
from the date of allotment.
|
Company Name | No. of Shares | Market Value Rs Lakhs | % of assets |
Equity & Equity Related Total | 11905.04 | 100.08 | |
Healthcare Equipment & Supplies | |||
Poly Medicure Ltd. | 9236 | 188.00 | 1.58 |
Healthcare Services | |||
Max Healthcare Institute Ltd. | 180440 | 1764.88 | 14.84 |
Fortis Healthcare Ltd. | 126515 | 775.16 | 6.52 |
Krishna Institute Of Medical Sciences Ltd. | 59598 | 310.54 | 2.61 |
Syngene International Ltd. | 43903 | 286.42 | 2.41 |
Narayana Hrudayalaya Ltd. | 16488 | 238.17 | 2.00 |
Global Health Ltd. | 20180 | 232.00 | 1.95 |
Aster Dm Healthcare Ltd. | 53256 | 214.60 | 1.80 |
Dr. Lal Path Labs Ltd. | 9084 | 209.88 | 1.76 |
Rainbow Childrens Medicare Ltd. | 12105 | 150.05 | 1.26 |
Metropolis Healthcare Ltd. | 6309 | 99.97 | 0.84 |
Pharmaceuticals & Biotechnology | |||
Lupin Ltd. | 58606 | 1116.24 | 9.38 |
Aurobindo Pharma Ltd. | 67909 | 718.68 | 6.04 |
Alkem Laboratories Ltd. | 12905 | 599.59 | 5.04 |
Mankind Pharma Ltd. | 25240 | 578.15 | 4.86 |
Laurus Labs Ltd. | 95592 | 503.96 | 4.24 |
Glenmark Pharmaceuticals Ltd. | 36586 | 467.92 | 3.93 |
Ipca Laboratories Ltd. | 32973 | 446.90 | 3.76 |
Abbott India Ltd. | 1265 | 384.50 | 3.23 |
Suven Pharmaceuticals Ltd. | 30840 | 374.61 | 3.15 |
Biocon Ltd. | 109299 | 330.57 | 2.78 |
Gland Pharma Ltd. | 19319 | 299.99 | 2.52 |
J.B.Chemicals & Pharmaceuticals Ltd. | 17371 | 285.64 | 2.40 |
Piramal Pharma Ltd. | 149602 | 284.08 | 2.39 |
Ajanta Pharma Ltd. | 10223 | 254.14 | 2.14 |
Glaxosmithkline Pharmaceuticals Ltd. | 10051 | 248.80 | 2.09 |
Natco Pharma Ltd. | 21731 | 167.48 | 1.41 |
Granules India Ltd. | 35175 | 162.44 | 1.37 |
Sanofi India Ltd. | 2209 | 110.71 | 0.93 |
Alembic Pharmaceuticals Ltd. | 13577 | 100.97 | 0.85 |
Repo | 18.90 | 0.16 | |
Portfolio Total | 11923.94 | 100.24 | |
Net Current Liabilities | -29.46 | -0.24 | |
Net Assets | 11894.48 | 100.00 |
Issuer Name | % to NAV |
Max Healthcare Institute Ltd. | 14.84 |
Lupin Laboratories Ltd. | 9.38 |
Fortis Healthcare Ltd. | 6.52 |
Aurobindo Pharma Ltd. | 6.04 |
Alkem Laboratories Ltd. | 5.04 |
Mankind Pharma Ltd | 4.86 |
Laurus Labs Ltd. | 4.24 |
Glenmark Pharmaceuticals Ltd. | 3.93 |
Ipca Labs | 3.76 |
Abbott India Ltd. | 3.23 |
Total | 61.84 |
Large Cap | 0.00% |
Mid Cap | 66.96% |
Small Cap | 33.04% |
Market Capitalisation is as per list provided by AMFI. |